| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.084 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |